Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Bonista, Osteotide, rhPTH (1-34) (Virchow/Sun) + [2] |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Primary osteoporosis | AU | 02 May 2024 | |
Glucocorticoid-induced osteoporosis | EU | 18 Nov 2022 | |
Glucocorticoid-induced osteoporosis | IS | 18 Nov 2022 | |
Glucocorticoid-induced osteoporosis | LI | 18 Nov 2022 | |
Glucocorticoid-induced osteoporosis | NO | 18 Nov 2022 | |
Osteoporosis, Postmenopausal | EU | 18 Nov 2022 | |
Osteoporosis, Postmenopausal | IS | 18 Nov 2022 | |
Osteoporosis, Postmenopausal | LI | 18 Nov 2022 | |
Osteoporosis, Postmenopausal | NO | 18 Nov 2022 | |
Osteoporotic Fractures | EU | 18 Nov 2022 | |
Osteoporotic Fractures | IS | 18 Nov 2022 | |
Osteoporotic Fractures | LI | 18 Nov 2022 | |
Osteoporotic Fractures | NO | 18 Nov 2022 |